34 related articles for article (PubMed ID: 7582302)
1. The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases.
Butrous G
Glob Cardiol Sci Pract; 2014; 2014(3):257-90. PubMed ID: 25780785
[TBL] [Abstract][Full Text] [Related]
2. Prenatal programming of pulmonary hypertension induced by chronic hypoxia or ductal ligation in sheep.
Papamatheakis DG; Chundu M; Blood AB; Wilson SM
Pulm Circ; 2013 Dec; 3(4):757-80. PubMed ID: 25006393
[TBL] [Abstract][Full Text] [Related]
3. Platelets in pulmonary hypertension: a causative role or a simple association?
Zanjani KS
Iran J Pediatr; 2012 Jun; 22(2):145-57. PubMed ID: 23056879
[TBL] [Abstract][Full Text] [Related]
4. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
Chester M; Seedorf G; Tourneux P; Gien J; Tseng N; Grover T; Wright J; Stasch JP; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L755-64. PubMed ID: 21856817
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension.
Farrow KN; Steinhorn RH
Handb Exp Pharmacol; 2011; (204):251-77. PubMed ID: 21695644
[TBL] [Abstract][Full Text] [Related]
6. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.
Chester M; Tourneux P; Seedorf G; Grover TR; Gien J; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2009 Aug; 297(2):L318-25. PubMed ID: 19465519
[TBL] [Abstract][Full Text] [Related]
7. Vardenafil, but not sildenafil or tadalafil, has calcium-channel blocking activity in rabbit isolated pulmonary artery and human washed platelets.
Toque HA; Teixeira CE; Priviero FB; Morganti RP; Antunes E; De Nucci G
Br J Pharmacol; 2008 Jun; 154(4):787-96. PubMed ID: 18536732
[TBL] [Abstract][Full Text] [Related]
8. Inhaled NO as a therapeutic agent.
Bloch KD; Ichinose F; Roberts JD; Zapol WM
Cardiovasc Res; 2007 Jul; 75(2):339-48. PubMed ID: 17544387
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.
Ghofrani HA; Osterloh IH; Grimminger F
Nat Rev Drug Discov; 2006 Aug; 5(8):689-702. PubMed ID: 16883306
[TBL] [Abstract][Full Text] [Related]
10. Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management.
Ostrea EM; Villanueva-Uy ET; Natarajan G; Uy HG
Paediatr Drugs; 2006; 8(3):179-88. PubMed ID: 16774297
[TBL] [Abstract][Full Text] [Related]
11. Selective type 5 phosphodiesterase inhibition alters pulmonary hemodynamics and lung liquid production in near-term fetal lambs.
Dukarm RC; Steinhorn RH; Russell JA; Lakshminrusimha S; Swartz D; Cummings JJ
J Appl Physiol (1985); 2005 Dec; 99(6):2331-6. PubMed ID: 16123210
[TBL] [Abstract][Full Text] [Related]
12. Preventive effect of zaprinast and 3-isobutyl, 1-methylxanthine (phosphodiesterase inhibitors) on gastric injury induced by nonsteroidal antiinflammatory drugs in rats.
Herrerías JM; Esteban JM; Caballero-Plasencia AM; Valenzuela-Barranco M; Motilva V; Alarcón C; Martín J; Herrerías JM; Esteban P
Dig Dis Sci; 2003 May; 48(5):986-91. PubMed ID: 12772800
[TBL] [Abstract][Full Text] [Related]
13. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
Hussain MB; Hobbs AJ; MacAllister RJ
Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
[TBL] [Abstract][Full Text] [Related]
14. Disruption of fas receptor signaling by nitric oxide in eosinophils.
Hebestreit H; Dibbert B; Balatti I; Braun D; Schapowal A; Blaser K; Simon HU
J Exp Med; 1998 Feb; 187(3):415-25. PubMed ID: 9449721
[TBL] [Abstract][Full Text] [Related]
15. Inhaled nitric oxide in neonates.
Finer N
Arch Dis Child Fetal Neonatal Ed; 1997 Sep; 77(2):F81-4. PubMed ID: 9377150
[No Abstract] [Full Text] [Related]
16. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.
Thusu KG; Morin FC; Russell JA; Steinhorn RH
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1605-10. PubMed ID: 7582302
[TBL] [Abstract][Full Text] [Related]
17. Site-specific effect of guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition in isolated lamb lungs.
Steinhorn RH; Gordon JB; Tod ML
Crit Care Med; 2000 Feb; 28(2):490-5. PubMed ID: 10708189
[TBL] [Abstract][Full Text] [Related]
18. Selective pulmonary vasodilation induced by aerosolized zaprinast.
Ichinose F; Adrie C; Hurford WE; Bloch KD; Zapol WM
Anesthesiology; 1998 Feb; 88(2):410-6. PubMed ID: 9477062
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
